Related Experiment Video
Updated: Feb 24, 2026

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
Machine Learning-Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease
Ofer Isakov1, Iris Dotan, Shay Ben-Shachar
1*Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; †Department of Gastroenterology and Liver Diseases, IBD Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; and ‡Genetic Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Researchers developed a machine learning approach to identify new genes linked to inflammatory bowel diseases (IBD). This method successfully pinpointed 67 novel candidate IBD-risk genes for further investigation.
Area of Science:
- Genetics and Genomics
- Immunology
- Computational Biology
Background:
- Inflammatory bowel diseases (IBD) are chronic conditions influenced by genetic, immune, and environmental factors.
- Hundreds of genes are implicated in IBD, but many more likely contribute to disease development.
- Identifying novel IBD-risk genes is crucial for understanding disease mechanisms.
Purpose of the Study:
- To develop and apply a machine learning-based gene prioritization method.
- To identify novel candidate genes associated with IBD risk.
- To enhance the understanding of IBD pathogenesis.
Main Methods:
- Collected known IBD genes from genome-wide association studies.
- Annotated genes with expression and pathway information.
- Trained a machine learning model to score and classify 16,390 genes for IBD risk.
Main Results:
- Identified immune/inflammatory responses, cell adhesion, cytokine-cytokine interaction, and sulfur metabolism pathways as relevant to IBD.
- IBD genes received significantly higher prediction scores than non-IBD genes (P < 10).
- Identified 67 novel candidate IBD-risk genes lacking prior IBD publications.
Conclusions:
- The machine learning method effectively distinguished IBD-risk genes using expression and annotation data.
- The study successfully identified novel candidate IBD-risk genes.
- These findings offer new targets for IBD research and may improve understanding of the disease.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

